Cowen Financial Products LLC 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:40 pm Sale | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 0 0.000% | -5,629,103 (Position Closed) | Filing |
| 2024-02-02 12:08 pm Purchase | 2023-12-29 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 5,629,103 7.600% | 440,737 (+8.49%) | Filing |
| 2023-01-11 11:50 am Purchase | 2022-12-30 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 5,188,366 6.450% | 1,924,216 (+58.95%) | Filing |
| 2022-08-18 3:38 pm Purchase | 2022-08-05 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 3,264,150 6.560% | 3,264,150 (New Position) | Filing |